Sigrid TherapeuticsSEK 45M
Sigrid Therapeutics develops gut-local consumer-health products based on SiPore, a technology that interacts with digestive enzymes.
New startup rounds, lead investors and the businesses behind the funding.
1 round · $4.9M disclosed · $4.9M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| Sigrid Therapeutics Sigrid Therapeutics develops gut-local consumer-health products based on SiPore, a technology that interacts with digestive enzymes. | SEK 45M | Undisclosed Consumer health | — |
Sigrid Therapeutics develops gut-local consumer-health products based on SiPore, a technology that interacts with digestive enzymes.
77 sourced rounds, with company profiles and participating investors.
27 sourced rounds, with company profiles and participating investors.
5 sourced rounds, with company profiles and participating investors.
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01Lightspeed Venture Partners | 23 | 6 | Temporal TechnologiesNeko Health |
| 02Y Combinator | 22 | 1 | SpottConveo |
| 03Andreessen Horowitz | 21 | 7 | ArmadinEliseAI |
| 04Accel | 21 | 6 | ArmadinEma |